Quality-adjusted life years and EQ-5D: An introduction;Kvalitetsjusterade levnadsår och EQ-5D: En introduktion

Lakartidningen

Volumn 103, Issue 21-22, 2006, Pages 1734-1739

  Henriksson, Martin ^a   Burström, Kristina ^b,c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MALE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; SURVIVAL RATE;

ACTIVITIES OF DAILY LIVING; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; SURVIVAL RATE;

EID: 33745283611     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1997.
2. Williams A. Economics of coronary artery bypass grafting. BMJ 1985;291:326-9.
3. Johannesson M. Theory and methods of economic evaluation of health care. Dordrecht, Boston: Kluwer; 1996.
4. Anell A, Carlsson P, Eliasson M. Hälsoekonomi spelar en allt större roll för sjukvårdens proriteringar. Läkartidningen 2006, in press.
5. Läkemedelsförmånsnämnden. Läkemedelsfö rmånsnämndens allmänna råd om ekonomiska utvärderingar: 2003 [citerad 25 nov 2005]. 〈http://www.lfn.se〉.
6. Burström K, Johannesson M, Diderichsen F. The value of the change in health in Sweden 1980/81 to 1996/97. Health Econ 2003;12:637-54.
7. Bartha E, Carlsson P, Kalman S. Evaluation of costs and effects of epidural analgesia and patient-controlled intravenous analgesia after major abdominal surgery. British Journal of Anaesthesia. Epub 2005 Oct 28.
8. Johannesson M. Should we aggregate relative or absolute changes in QALYs? Health Econ 2001;10:573-7.
9. Williams A. Intergenerational equity: an exploration of the 'fair innings' argument. Health Econ 1997;6:117-32.
10. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-43.
11. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108.
12. Burström K, Rehnberg c. Hälsorelaterad livskvalitet i Stockholms län 2002. Resultat per utbildningsnivå, födelseland samt sysselsättningsgrupp - en befolkningsundersökning med EQ-5D. Stockholm: Stockholms läns landsting, Centrum för folkhälsa, enheten för socialmedicin och hälsoekonomi; 2006. Rapport 2006:1.
13. Henriksson M, Carlsson P. Att mäta hälsorelaterad livskvalitet - en beskrivning av intrumentet EQ-5D. Linköping:2002. CMT Rapport 2002:1.
14. Kvalitetsutveckling [citerad 5 nov 2005]. http://www.hsn.sll.se/ kvalitetsutveckling
15. Burström K, Johannesson M, Diderichsen F. A comparison of individual and social time trade-off values for health states in the general population. Health Policy 2006;76(3):359-70.
16. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II investigators. Fast revascularisation during instability in coronary artery disease. Lancet 2000;356:9-16.
17. Janzon M. Treatment strategies in unstable coronary artery disease, economic and quality of life evaluations [dissertation]. Linköping: 811:Linköping university;2003. Medical dissertation No 811.
18. Karlsson G, Johannesson M. The decision rules of cost-effectiveness analysis. Pharmacoeconomics 1996;9:113-20.
19. Henriksson M, Lundgren F. Decision-analytical model with lifetime estimation of costs and health outcomes for one-time screening for abdominal aortic aneurysm in 65-year-old men. Br J Surg 2005;92:976-83.
20. Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004;13:873-84.